Generics

    The fight for inclusive medicine is decades-old, but it’s a war that’s far from being won. Take diabetes, which affects 415 million people. Over the past 60 years, the price of insulin has gone up from 77c to $250, 43 times more than U.S. inflation. Such patent-driven predatory pricing is only possible because the $27 billion market is controlled by just three companies, Eili Lilly, Novo Nordisk and Sanofi. Now the Open Insulin Project of biotech company Counter Culture Labs is reverse engineering the drug to make open source, generic DIY-insulin. I hope they – and others like them – succeed.

    — Wayne Visser

    More on Society & Justice

    From Purpose Inspired: Reflections on Conscious Living, Volume 2. Buy on Lulu ↗